Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, we are dedicated to achieving these goals in Washington, D.C. and across the country.

Featured Blogs

What’s missing in the current drug pricing plan

Brian Newell
Last week, a congressional forum looked at the role pharmacy benefit managers (PBMs) play in determining what patients pay out of pocket for prescription medicines.

3 things to know about the importance of post-approval research and development

Andrew Powaleny
As we're seeing with the COVID-19 vaccines today, scientists and physicians continue to generate information on a new medicine or vaccine long after FDA approval.

New study finds more than half of brand medicine spending goes to the supply chain and others

Brian Newell
More than half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders in 2020 according to a new analysis from the Berkeley Research Group (BRG).